Improved drug design and testing during the preclinical and clinical trial phases. Personalized medicine approaches, including pharmacogenomics, to tailor drug therapy based on individual genetic profiles. Enhanced education and training for healthcare providers regarding the safe use of medications. Implementation of electronic prescribing and decision support systems to reduce medication errors. Promotion of patient awareness and engagement in their own healthcare.
